{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:32:13Z","timestamp":1773275533504,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejpn.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T11:45:34Z","timestamp":1701863134000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-7892","authenticated-orcid":false,"given":"In\u00eas","family":"Cascais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurdes","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7841-5490","authenticated-orcid":false,"given":"Rosa","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena Ferreira","family":"Mansilha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejpn.2023.12.001_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/brv.12674","article-title":"The hallmarks of myotonic dystrophy type 1 muscle dysfunction","volume":"96","author":"Ozimski","year":"2021","journal-title":"Biol. Rev. Camb. Phil. Soc."},{"issue":"3","key":"10.1016\/j.ejpn.2023.12.001_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000524734","article-title":"Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis","volume":"56","author":"Liao","year":"2022","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ejpn.2023.12.001_bib3","author":"Darras"},{"key":"10.1016\/j.ejpn.2023.12.001_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/B978-0-444-59565-2.00009-5","article-title":"Congenital and infantile myotonic dystrophy","volume":"113","author":"Echenne","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2023.12.001_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010354","article-title":"Molecular and clinical implications of variant repeats in myotonic dystrophy type 1","volume":"23","author":"Peric","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpn.2023.12.001_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2017.01.007","article-title":"Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes","volume":"44","author":"Yum","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"7","key":"10.1016\/j.ejpn.2023.12.001_bib7","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1212\/WNL.0000000000011425","article-title":"Population-based prevalence of myotonic dystrophy type 1 using genetic analysis of statewide blood screening program","volume":"96","author":"Johnson","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejpn.2023.12.001_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/archdischild-2018-314837","article-title":"Myotonic dystrophy type 1: clinical manifestations in children and adolescents","volume":"104","author":"Ho","year":"2019","journal-title":"Arch. Dis. Child."},{"issue":"5","key":"10.1016\/j.ejpn.2023.12.001_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/CPJ.0000000000000646","article-title":"Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1","volume":"9","author":"Johnson","year":"2019","journal-title":"Neurol Clin Pract"},{"issue":"4","key":"10.1016\/j.ejpn.2023.12.001_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40271-019-00357-y","article-title":"Health-related quality of life in patients with adult-onset myotonic dystrophy type 1: a systematic review","volume":"12","author":"Landfeldt","year":"2019","journal-title":"Patient"},{"issue":"7","key":"10.1016\/j.ejpn.2023.12.001_bib11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1017\/S0012162205000927","article-title":"Myotonic dystrophy: muscle involvement in relation to disease type and size of expanded CTG-repeat sequence","volume":"47","author":"Kroksmark","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2023.12.001_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejpn.2022.05.008","article-title":"Cognitive, neuropsychological and emotional-behavioural functioning in a sample of children with myotonic dystrophy type 1","volume":"39","author":"Ricci","year":"2022","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2023.12.001_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semerg.2022.01.013","article-title":"[Cognitive impairment in myotonic dystrophy type 1 (Steinert's disease)]","volume":"48","author":"Rosado Bartolom\u00e9","year":"2022","journal-title":"Semergen"},{"issue":"3","key":"10.1016\/j.ejpn.2023.12.001_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nmd.2023.01.008","article-title":"Respiratory function and sleep in children with myotonic dystrophy type 1","volume":"33","author":"Cheminelle","year":"2023","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"10.1016\/j.ejpn.2023.12.001_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nmd.2022.01.008","article-title":"Genitourinary and lower gastrointestinal conditions in patients with myotonic dystrophy type 1: a systematic review of evidence and implications for clinical practice","volume":"32","author":"Fisette-Paulhus","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ejpn.2023.12.001_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.910660","article-title":"Cardiac manifestations of myotonic dystrophy in a pediatric cohort","volume":"10","author":"Brunet Garcia","year":"2022","journal-title":"Front Pediatr"},{"issue":"8","key":"10.1016\/j.ejpn.2023.12.001_bib17","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.1212\/WNL.0000000000006948","article-title":"A\u00a0large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management","volume":"92","author":"Lagrue","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ejpn.2023.12.001_bib18","first-page":"32","article-title":"Myotonic dystrophy type 1 clinical, electrophysiological and molecular characterization: experience at tertiary care centre","volume":"65","author":"Khadilkar","year":"2017","journal-title":"J.\u00a0Assoc. Phys. India"},{"issue":"4","key":"10.1016\/j.ejpn.2023.12.001_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5409\/wjcp.v4.i4.66","article-title":"Congenital and childhood myotonic dystrophy: current aspects of disease and future directions","volume":"4","author":"Ho","year":"2015","journal-title":"World J. Clin. Pediatr."},{"issue":"6","key":"10.1016\/j.ejpn.2023.12.001_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/mus.26716","article-title":"Clinical and genetic characteristics of childhood-onset myotonic dystrophy","volume":"60","author":"Stokes","year":"2019","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.ejpn.2023.12.001_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.nmd.2017.05.018","article-title":"Long-term follow-up of motor function and muscle strength in the congenital and childhood forms of myotonic dystrophy type 1","volume":"27","author":"Kroksmark","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ejpn.2023.12.001_bib22","article-title":"Myotonic dystrophy type1: 13years of experience at a tertiary hospital. Clinical and epidemiological study and genotype-phenotype correlation","author":"S\u00e1nchez Mar\u00edn","year":"2021","journal-title":"Neurologia"},{"issue":"2","key":"10.1016\/j.ejpn.2023.12.001_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/BPO.0b013e3181982bf6","article-title":"Orthopaedic manifestations of congenital myotonic dystrophy during childhood and adolescence","volume":"29","author":"Canavese","year":"2009","journal-title":"J.\u00a0Pediatr. Orthop."},{"key":"10.1016\/j.ejpn.2023.12.001_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cortex.2017.08.008","article-title":"The cognitive profile of myotonic dystrophy type 1: a systematic review and meta-analysis","volume":"95","author":"Okkersen","year":"2017","journal-title":"Cortex"},{"issue":"10","key":"10.1016\/j.ejpn.2023.12.001_bib25","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/dmcn.14161","article-title":"Cognitive and adaptive functioning in congenital and childhood forms of myotonic dystrophy type 1: a longitudinal study","volume":"61","author":"Lindeblad","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ejpn.2023.12.001_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/1752-1947-8-427","article-title":"Concurrence of myotonic dystrophy and epilepsy: a case report","volume":"8","author":"Worku","year":"2014","journal-title":"J.\u00a0Med. Case Rep."},{"issue":"3","key":"10.1016\/j.ejpn.2023.12.001_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nmd.2018.12.002","article-title":"Respiratory dysfunction in myotonic dystrophy type 1: a systematic review","volume":"29","author":"Hawkins","year":"2019","journal-title":"Neuromuscul. Disord."},{"issue":"10","key":"10.1016\/j.ejpn.2023.12.001_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cardfail.2019.07.548","article-title":"Prevalence of left ventricular systolic dysfunction in myotonic dystrophy type 1: a systematic review","volume":"26","author":"Russo","year":"2020","journal-title":"J.\u00a0Card. Fail."},{"issue":"7","key":"10.1016\/j.ejpn.2023.12.001_bib29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/dmcn.12948","article-title":"Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy","volume":"58","author":"Johnson","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2023.12.001_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mus.26632","article-title":"Patient-reported study of the impact of pediatric-onset myotonic dystrophy","volume":"60","author":"Hunter","year":"2019","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.ejpn.2023.12.001_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neurol.2016.08.003","article-title":"Unravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classification","volume":"172","author":"De Antonio","year":"2016","journal-title":"Rev. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2023.12.001_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mus.26420","article-title":"The myotonic dystrophy experience: a North American cross-sectional study","volume":"59","author":"Hagerman","year":"2019","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ejpn.2023.12.001_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nrl.2019.01.001","article-title":"Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease","volume":"35","author":"Guti\u00e9rrez Guti\u00e9rrez","year":"2020","journal-title":"Neurologia"},{"issue":"3","key":"10.1016\/j.ejpn.2023.12.001_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103489","article-title":"The myotonic dystrophy type 1 drug development pipeline: 2022 edition","volume":"28","author":"Pascual-Gilabert","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpn.2023.12.001_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","article-title":"A\u00a0Phase 2 study of AMO-02 (tideglusib) in congenital and childhood-onset myotonic dystrophy type 1 (DM1)","volume":"112","author":"Horrigan","year":"2020","journal-title":"Pediatr. Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2023.12.001_bib36","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1212\/WNL.0000000000011002","article-title":"Mexiletine in myotonic dystrophy type 1: a randomized, double-blind, placebo-controlled trial","volume":"96","author":"Heatwole","year":"2021","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ejpn.2023.12.001_bib37","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/brain\/awy231","article-title":"Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial","volume":"141","author":"Bassez","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ejpn.2023.12.001_bib38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12967-022-03806-9","article-title":"Calcitriol increases MBNL1 expression and alleviates myotonic dystrophy phenotypes in HSALR mouse models","volume":"20","author":"Huang","year":"2022","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ejpn.2023.12.001_bib39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.omtn.2020.07.021","article-title":"Therapeutic potential of AntagomiR-23b for treating myotonic dystrophy","volume":"21","author":"Cerro-Herreros","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.ejpn.2023.12.001_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041118","article-title":"BlockmiR AONs as site-specific therapeutic MBNL modulation in myotonic dystrophy 2D and 3D muscle cells and HSALR mice","volume":"15","author":"Overby","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982300185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982300185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:42:15Z","timestamp":1761072135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109037982300185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"alternative-id":["S109037982300185X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.12.001","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}